Darrin R. Uecker is a seasoned technology executive who currently serves as the Chief Technology Officer and Director at Pulse Biosciences Inc. With a robust background in engineering and product development, Uecker has been instrumental in driving innovation at Pulse Biosciences, a company focused on developing novel medical devices using nanosecond pulsed field ablation (nsPFA) technology. Prior to joining Pulse Biosciences, Uecker held several key positions at leading technology firms, where he honed his skills in managing complex projects and leading cross-functional teams. At Pulse Biosciences, Uecker's role as CTO involves overseeing the company's technological advancements and ensuring the successful development and commercialization of their medical devices. His strategic vision has been crucial in navigating the company through the rigorous processes of clinical trials and regulatory approvals. Under his leadership, Pulse Biosciences has made significant strides in the field of medical technology, particularly in the application of nsPFA for treating various medical conditions. Uecker's contributions have not only propelled the company forward but have also positioned it as a pioneer in the industry. In addition to his executive responsibilities, Uecker serves on the board of directors at Pulse Biosciences, where he provides valuable insights and guidance on the company's overall strategy. His dual role as CTO and director underscores his deep commitment to the company's mission and success. Uecker's extensive experience and leadership have been pivotal in establishing Pulse Biosciences as a leader in the development of innovative medical solutions, and his ongoing contributions continue to drive the company's growth and impact in the healthcare sector.